Jan 9, 2026 08:05AM
Jan 9, 2026 08:04AM
Nov 19, 2025 06:40AM
Nov 13, 2025 04:06PM
Nov 13, 2025 04:05PM
Nov 6, 2025 07:00AM
Oct 30, 2025 07:01AM Cartesian Therapeutics names CEO Carsten Brunn as board chairman
Oct 30, 2025 07:00AM
Aug 7, 2025 07:00AM
May 30, 2025 07:01AM
May 30, 2025 07:00AM
May 13, 2025 07:00AM
May 8, 2025 07:00AM
May 2, 2025 07:05AM Cartesian Therapeutics Announces New Employment Inducement Grants
Apr 8, 2025 07:01AM
Apr 8, 2025 07:00AM
Apr 2, 2025 07:05AM
Apr 1, 2025 07:00AM
Mar 13, 2025 07:00AM
Jan 28, 2025 06:39AM
Jan 27, 2025 07:00AM Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis
Jan 13, 2025 07:00AM
Dec 3, 2024 06:01AM
Dec 3, 2024 06:00AM
Nov 21, 2024 07:00AM
Nov 7, 2024 07:00AM
Nov 5, 2024 09:00AM
Oct 15, 2024 07:03AM Cartesian Therapeutics (RNAC) Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis
Oct 15, 2024 07:00AM
Sep 13, 2024 06:44AM
Sep 9, 2024 07:03AM
Sep 9, 2024 07:00AM
Sep 3, 2024 07:05AM
Sep 3, 2024 07:00AM
Aug 9, 2024 07:33AM Cartesian Therapeutics (RNAC) PT Lowered to $41 at Needham
Aug 8, 2024 07:00AM
Jul 3, 2024 06:40AM
Jul 3, 2024 06:33AM
Jul 2, 2024 04:07PM
Jul 2, 2024 04:05PM
Jul 2, 2024 06:32AM
Jul 2, 2024 06:31AM Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
Jul 2, 2024 06:30AM
Jul 2, 2024 06:30AM
May 22, 2024 07:01AM
May 22, 2024 07:00AM
May 8, 2024 07:00AM
Mar 28, 2024 04:05PM
Mar 7, 2024 07:00AM Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Mar 5, 2024 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All